Access

Research Highlights

Nature Reviews Clinical Oncology 2, 120 (1 March 2005) | doi:10.1038/ncponc0117

Radioimmunotherapy for follicular lymphoma

Kaminski MS et al. (2005) 131I-tositumomab therapy as initial treatment for follicular lymphoma. New Engl J Med 352: 441–449 The radioimmunoconjugate 131I-tositumomab has shown promise in the treatment of recurrent follicular lymphoma.